NATCO Pharma Limited (NATCOPHARM.NS)
INR 775.5
(3.88%)
INR 775.5
(3.88%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 25.73 Billion INR | 23.59% |
| 2022 | 20.79 Billion INR | 70.0% |
| 2021 | 12.23 Billion INR | 13.03% |
| 2020 | 10.82 Billion INR | -21.44% |
| 2019 | 13.77 Billion INR | -13.88% |
| 2018 | 15.99 Billion INR | -2.91% |
| 2017 | 16.47 Billion INR | 22.43% |
| 2016 | 13.45 Billion INR | 83.94% |
| 2015 | 7.31 Billion INR | 36.67% |
| 2014 | 5.35 Billion INR | 17.67% |
| 2013 | 4.54 Billion INR | 21.5% |
| 2012 | 3.74 Billion INR | 32.65% |
| 2011 | 2.82 Billion INR | -21.25% |
| 2010 | 3.58 Billion INR | 2.58% |
| 2009 | 3.49 Billion INR | 2.34% |
| 2008 | 3.41 Billion INR | 43.52% |
| 2007 | 2.37 Billion INR | 52.59% |
| 2006 | 1.55 Billion INR | 338.58% |
| 2005 | 355.48 Million INR | -8.44% |
| 2004 | 388.24 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 FY | 25.7 Billion INR | 23.59% |
| 2023 Q4 | 9.96 Billion INR | 36.91% |
| 2023 Q1 | 8.15 Billion INR | -13.65% |
| 2023 Q2 | 5.96 Billion INR | -26.88% |
| 2023 Q3 | 7.27 Billion INR | 22.02% |
| 2022 Q3 | 6.39 Billion INR | 69.58% |
| 2022 Q1 | 3.26 Billion INR | -55.72% |
| 2022 Q4 | 9.44 Billion INR | 47.69% |
| 2022 FY | 20.79 Billion INR | 70.0% |
| 2022 Q2 | 3.77 Billion INR | 15.57% |
| 2021 Q3 | 1.4 Billion INR | -70.05% |
| 2021 FY | 12.23 Billion INR | 13.03% |
| 2021 Q1 | 2.84 Billion INR | -14.04% |
| 2021 Q2 | 4.67 Billion INR | 64.21% |
| 2021 Q4 | 7.36 Billion INR | 426.36% |
| 2020 Q1 | 6.07 Billion INR | 57.95% |
| 2020 Q4 | 3.31 Billion INR | 282.48% |
| 2020 Q3 | -1.81 Billion INR | -166.7% |
| 2020 Q2 | 2.72 Billion INR | -55.2% |
| 2020 FY | 10.82 Billion INR | -21.44% |
| 2019 Q4 | 3.84 Billion INR | 88.2% |
| 2019 FY | 13.77 Billion INR | -13.88% |
| 2019 Q1 | 3.66 Billion INR | -11.96% |
| 2019 Q2 | 3.9 Billion INR | 6.6% |
| 2019 Q3 | 2.04 Billion INR | -47.71% |
| 2018 Q2 | 4.51 Billion INR | 0.69% |
| 2018 Q1 | 4.48 Billion INR | -0.6% |
| 2018 Q4 | 4.16 Billion INR | 67.66% |
| 2018 FY | 15.99 Billion INR | -2.91% |
| 2018 Q3 | 2.48 Billion INR | -45.03% |
| 2017 Q2 | 4.96 Billion INR | 58.19% |
| 2017 Q4 | 4.51 Billion INR | -30.01% |
| 2017 Q3 | 6.44 Billion INR | 29.9% |
| 2017 Q1 | 3.13 Billion INR | -1.54% |
| 2017 FY | 16.47 Billion INR | 22.43% |
| 2016 FY | 13.45 Billion INR | 83.94% |
| 2016 Q1 | 2.31 Billion INR | 12.89% |
| 2016 Q2 | 4.37 Billion INR | 89.0% |
| 2016 Q4 | 3.18 Billion INR | -30.81% |
| 2016 Q3 | 4.6 Billion INR | 5.29% |
| 2015 Q3 | 2.94 Billion INR | 72.31% |
| 2015 Q1 | 1.55 Billion INR | 6.55% |
| 2015 Q4 | 2.05 Billion INR | -30.41% |
| 2015 FY | 7.31 Billion INR | 36.67% |
| 2015 Q2 | 1.7 Billion INR | 10.01% |
| 2014 Q2 | 1.21 Billion INR | -16.2% |
| 2014 Q4 | 1.45 Billion INR | 0.85% |
| 2014 Q3 | 1.44 Billion INR | 19.3% |
| 2014 Q1 | 1.44 Billion INR | 15.88% |
| 2014 FY | 5.35 Billion INR | 17.67% |
| 2013 Q2 | 1.28 Billion INR | 22.1% |
| 2013 Q4 | 1.24 Billion INR | 11.64% |
| 2013 FY | 4.54 Billion INR | 21.5% |
| 2013 Q1 | 1.05 Billion INR | -4.36% |
| 2013 Q3 | 1.11 Billion INR | -12.83% |
| 2012 FY | 3.74 Billion INR | 32.65% |
| 2012 Q3 | 947.02 Million INR | 4.1% |
| 2012 Q2 | 909.7 Million INR | -20.02% |
| 2012 Q1 | 1.13 Billion INR | 39.9% |
| 2012 Q4 | 1.09 Billion INR | 15.98% |
| 2011 FY | 2.82 Billion INR | -21.25% |
| 2011 Q2 | 776.9 Million INR | -1.43% |
| 2011 Q3 | 703.56 Million INR | -9.44% |
| 2011 Q4 | 813 Million INR | 15.55% |
| 2011 Q1 | 788.2 Million INR | 0.0% |
| 2010 FY | 3.58 Billion INR | 2.58% |
| 2009 FY | 3.49 Billion INR | 2.34% |
| 2008 FY | 3.41 Billion INR | 43.52% |
| 2007 FY | 2.37 Billion INR | 52.59% |
| 2006 FY | 1.55 Billion INR | 338.58% |
| 2005 FY | 355.48 Million INR | -8.44% |
| 2004 FY | 388.24 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 3.901% |
| Hester Biosciences Limited | 1.27 Billion INR | -1920.649% |
| Aarti Drugs Limited | 8.31 Billion INR | -209.468% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -341.338% |
| Albert David Limited | 1.4 Billion INR | -1727.728% |
| Alembic Limited | 1 Billion INR | -2473.325% |
| Alkem Laboratories Limited | 52.29 Billion INR | 50.789% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -5591.879% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -1648.6% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -205049.462% |
| Brooks Laboratories Limited | 65.62 Million INR | -39119.75% |
| Eris Lifesciences Limited | 10.42 Billion INR | -146.826% |
| FDC Limited | 6.58 Billion INR | -290.756% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -106.998% |
| Gufic Biosciences Limited | 4.07 Billion INR | -531.755% |
| Hikal Limited | 5.95 Billion INR | -331.957% |
| Ind-Swift Limited | 2.17 Billion INR | -1084.609% |
| Innova Captab Limited | 3.46 Billion INR | -642.862% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -445.358% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -3843.671% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -31.019% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -1263.955% |
| Lupin Limited | 125.09 Billion INR | 79.427% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -3623.417% |
| Medico Remedies Limited | 262.14 Million INR | -9717.505% |
| Morepen Laboratories Limited | 6.16 Billion INR | -317.705% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -433.578% |
| Orchid Pharma Limited | 2.32 Billion INR | -1009.165% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -345.152% |
| RPG Life Sciences Limited | 2.48 Billion INR | -936.488% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -4047.777% |
| Sigachi Industries Limited | 2 Billion INR | -1185.333% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 1654.2% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -524.164% |
| Themis Medicare Limited | 2.42 Billion INR | -963.468% |
| Unichem Laboratories Limited | 4.86 Billion INR | -429.011% |
| Vaishali Pharma Limited | 90.32 Million INR | -28393.296% |
| Wanbury Limited | 1.73 Billion INR | -1387.077% |
| Windlas Biotech Limited | 1.33 Billion INR | -1822.318% |
| ZIM Laboratories Limited | 1.26 Billion INR | -1929.952% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -522.663% |
| Ipca Laboratories Limited | 48.58 Billion INR | 47.028% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 90.044% |
| Venus Remedies Limited | 2.18 Billion INR | -1079.152% |
| Sakar Healthcare Limited | 699.58 Million INR | -3578.752% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 76.506% |
| Divi's Laboratories Limited | 32.44 Billion INR | 20.666% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -313.583% |
| Mankind Pharma Limited | 42.19 Billion INR | 39.01% |
| Sequent Scientific Limited | 2.97 Billion INR | -763.992% |
| Laurus Labs Limited | 15.44 Billion INR | -66.59% |
| Neuland Laboratories Limited | 8.24 Billion INR | -212.033% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | -68.662% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 62.885% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 79.446% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -1129.014% |
| Wockhardt Limited | 7.72 Billion INR | -233.368% |
| Bal Pharma Limited | 770.19 Million INR | -3241.491% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 84.27% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -596.427% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -4763.778% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | -179.542% |
| Shilpa Medicare Limited | 3.56 Billion INR | -622.536% |
| Valiant Laboratories Limited | 138.02 Million INR | -18545.357% |
| Ajanta Pharma Limited | 21.06 Billion INR | -22.18% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -22669.378% |
| Granules India Limited | 16.79 Billion INR | -53.197% |
| Medicamen Biotech Limited | 495.49 Million INR | -5093.998% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -4499.797% |
| Piramal Enterprises Limited | 8.04 Billion INR | -219.968% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 44.958% |
| Suven Life Sciences Limited | -200.79 Million INR | 12916.925% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 23765.94% |
| Strides Pharma Science Limited | 14.38 Billion INR | -78.87% |
| Indoco Remedies Limited | 8.04 Billion INR | -219.98% |
| Alpa Laboratories Limited | 188.89 Million INR | -13524.5% |
| Lasa Supergenerics Limited | 121.02 Million INR | -21164.15% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -6480.986% |